Advertisement
Advertisement
May 24, 2021
Prytime’s ER-Reboa Plus Catheter Receives UK and CE Mark Approvals
May 24, 2021—Prytime Medical Devices, Inc. announced it has received both United Kingdom and CE Mark approval for its next-generation ER-Reboa Plus catheter, which is designed for improved ease of use compared with the ER-Reboa catheter that it replaces in the market. The new “Reboa Refined” catheter is designed for controlling noncompressible truncal hemorrhage. The device previously received approvals in the United States and Canada.
According to the company, the ER-Reboa Plus catheter maintains the features of its predecessor, including an integrated arterial line for monitoring above-balloon blood pressure, on-label guidewire-free and image-free placement, low-profile 7-F sheath compatibility, and the company’s atraumatic P-tip to aid in positioning.
New features of the ER-Reboa Plus include a precaptured balloon for ease of use, dual-sided length and zone markers, and a “leave-behind” guidewire capability up to 0.025 inch to support transition to subsequent endovascular procedures, stated Prytime Medical Devices.
Advertisement
Advertisement
